• TINF2 Gene Mutation Analysis
  • Measles (Rubeola) Virus Culture, CSF
  • 15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
  • Beta-Glucuronidase, Blood
  • Bartonella Antibody, IgG and IgM, Serum
  • Bladder Tumor Antigen (BTA)
  • Alpha-galactosidase A (GLA) Mutation Analysis
  • Vancomycin-Resistant Enterococcus, Molecular Detection, PCR
  • Coccidioides Antibody, Spinal Fluid
  • Signal Recognition Particle Antibody (SRP)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /DetermaRx for Lung Cancer Disease Management
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

DetermaRx for Lung Cancer Disease Management
Medical Test

ICD10
Access to DetermaRx for Lung Cancer Disease Management is restricted.
Loading...